Table of Contents
Chapter 1. Global Gastric Cancer Diagnostic Market Executive Summary
1.1. Global Gastric Cancer Diagnostic Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Disease Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Gastric Cancer Diagnostic Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Gastric Cancer Diagnostic Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Incidences of Gastric Cancer
3.1.2. Technological Advancements in Diagnostics
3.1.3. Growing Geriatric Population
3.2. Market Challenges
3.2.1. High Cost of Diagnostic Tests
3.2.2. Limited Access to Healthcare in Some Regions
3.3. Market Opportunities
3.3.1. Growing Awareness of Early Diagnosis
3.3.2. Expansion into Emerging Markets
3.3.3. Increased Focus on Precision Medicine
Chapter 4. Global Gastric Cancer Diagnostic Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Gastric Cancer Diagnostic Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Gastric Cancer Diagnostic Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Reagents and Consumables
5.2.2. Instruments
Chapter 6. Global Gastric Cancer Diagnostic Market Size & Forecasts by Disease Type 2022-2032
6.1. Segment Dashboard
6.2. Global Gastric Cancer Diagnostic Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Adenocarcinoma
6.2.2. Gastric Lymphoma
6.2.3. Others
Chapter 7. Global Gastric Cancer Diagnostic Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Gastric Cancer Diagnostic Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Diagnostic Laboratories
7.2.3. Diagnostic Imaging Centers
Chapter 8. Global Gastric Cancer Diagnostic Market Size & Forecasts by Region 2022-2032
8.1. North America Gastric Cancer Diagnostic Market
8.1.1. U.S. Gastric Cancer Diagnostic Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Disease Type breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Gastric Cancer Diagnostic Market
8.2. Europe Gastric Cancer Diagnostic Market
8.2.1. U.K. Gastric Cancer Diagnostic Market
8.2.2. Germany Gastric Cancer Diagnostic Market
8.2.3. France Gastric Cancer Diagnostic Market
8.2.4. Spain Gastric Cancer Diagnostic Market
8.2.5. Italy Gastric Cancer Diagnostic Market
8.2.6. Rest of Europe Gastric Cancer Diagnostic Market
8.3. Asia-Pacific Gastric Cancer Diagnostic Market
8.3.1. China Gastric Cancer Diagnostic Market
8.3.2. India Gastric Cancer Diagnostic Market
8.3.3. Japan Gastric Cancer Diagnostic Market
8.3.4. Australia Gastric Cancer Diagnostic Market
8.3.5. South Korea Gastric Cancer Diagnostic Market
8.3.6. Rest of Asia Pacific Gastric Cancer Diagnostic Market
8.4. Latin America Gastric Cancer Diagnostic Market
8.4.1. Brazil Gastric Cancer Diagnostic Market
8.4.2. Mexico Gastric Cancer Diagnostic Market
8.4.3. Rest of Latin America Gastric Cancer Diagnostic Market
8.5. Middle East & Africa Gastric Cancer Diagnostic Market
8.5.1. Saudi Arabia Gastric Cancer Diagnostic Market
8.5.2. South Africa Gastric Cancer Diagnostic Market
8.5.3. Rest of Middle East & Africa Gastric Cancer Diagnostic Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Abbott Laboratories
9.3.3. Agilent Technologies, Inc.
9.3.4. Fulgent Genetics
9.3.5. Exact Sciences Corporation
9.3.6. MiRXES Pte Ltd
9.3.7. Bio-Rad Laboratories, Inc.
9.3.8. Hipro Biotechnology Co., Ltd.
9.3.9. Endofotonics Pte Ltd
9.3.10. Qiagen NV
9.3.11. PerkinElmer, Inc.
9.3.12. Thermo Fisher Scientific Inc.
9.3.13. Becton, Dickinson and Company
9.3.14. Siemens Healthineers AG
9.3.15. Illumina, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes